Valuation: Organon & Co.

Market Cap 355.04Cr 310.27Cr 286.3Cr 263.9Cr 497.41Cr 34TCr 508.45Cr 3.42TCr 1.35TCr 17TCr 1.33TCr 1.3TCr 58TCr P/E 2026 *
5.28x
P/E 2027 * 4.88x
Enterprise Value 1.05TCr 916.58Cr 845.79Cr 779.61Cr 1.47TCr 1,01000Cr 1.5TCr 10TCr 3.98TCr 49TCr 3.94TCr 3.85TCr 1,70300Cr EV / Sales 2026 *
1.71x
EV / Sales 2027 * 1.55x
Free-Float
99.53%
Yield 2026 *
0.59%
Yield 2027 * 0.77%
1 day+0.22%
Current month-0.15%
1 month+0.67%
3 months+38.52%
6 months+54.34%
Current year+88.56%
1 week 13.49
Extreme 13.49
13.53
1 month 13.39
Extreme 13.39
13.6
Current year 5.69
Extreme 5.69
13.6
1 year 5.69
Extreme 5.69
13.6
3 years 5.69
Extreme 5.69
24.08
5 years 5.69
Extreme 5.69
39.48
10 years 5.69
Extreme 5.69
39.48
Manager TitleAgeSince
Chief Executive Officer 61 26/10/2025
Director of Finance/CFO 59 02/06/2021
Compliance Officer - -
Director TitleAgeSince
Chairman 68 02/06/2021
Director/Board Member 78 02/06/2021
Director/Board Member 72 02/06/2021
Date Insider Type Main position Quantity % Market Cap.
12/06/26 Free

Director

17,857 0.0068%
12/06/26 Free

Director

17,857 0.0068%
12/06/26 Free

Director

17,857 0.0068%
Change 5-day change 1-year change 3-year change Capi.($)
+0.22%0.00%+42.92%-34.15% 355.04Cr
+0.85%-0.80%+52.79%+161.33% 1,05100Cr
+1.23%-1.53%+54.58%+59.08% 61TCr
+0.04%+2.58%+34.47%+86.33% 45TCr
+0.78%-0.71%+29.28%+24.10% 33TCr
+1.41%+0.58%+35.44%+40.67% 28TCr
-0.27%-1.87%+22.34%+22.51% 26TCr
-1.76%+2.37%-20.43%-38.00% 22TCr
-1.42%+0.80%+24.27%+57.50% 20TCr
-1.48%+3.43%+24.08%+71.67% 17TCr
Average -0.04%+0.48%+29.97%+45.10% 35.79TCr
Weighted average by Cap. +0.37%+0.02%+37.52%+79.52%

Financials

2026 *2027 *
Net sales 612.54Cr 535.3Cr 493.96Cr 455.31Cr 858.17Cr 59TCr 877.22Cr 5.9TCr 2.32TCr 29TCr 2.3TCr 2.25TCr 99TCr 623.62Cr 544.98Cr 502.89Cr 463.54Cr 873.69Cr 60TCr 893.08Cr 6.01TCr 2.36TCr 29TCr 2.34TCr 2.29TCr 1,01300Cr
Net income 67Cr 59Cr 54Cr 50Cr 94Cr 6.49TCr 97Cr 649.64Cr 255.52Cr 3.18TCr 253.12Cr 247.57Cr 11TCr 73Cr 64Cr 59Cr 54Cr 102.27Cr 7.03TCr 104.54Cr 703.62Cr 276.75Cr 3.44TCr 274.15Cr 268.14Cr 12TCr
Net Debt 693.8Cr 606.31Cr 559.49Cr 515.71Cr 972.01Cr 67TCr 993.59Cr 6.69TCr 2.63TCr 33TCr 2.61TCr 2.55TCr 1,12600Cr 612.69Cr 535.43Cr 494.08Cr 455.42Cr 858.39Cr 59TCr 877.44Cr 5.91TCr 2.32TCr 29TCr 2.3TCr 2.25TCr 99TCr
Logo Organon & Co.
Organon & Co. is a global healthcare company. The Company is engaged in developing and delivering health solutions through a portfolio of prescription therapies and medical devices within women's health, biosimilars and a franchise of established medicines across a range of therapeutic areas. It has a portfolio of approximately 70 medicines and products across a range of therapeutic areas. It has a portfolio of contraception and fertility brands, including Nexplanon, NuvaRing, and Follistim AQ. Its Biosimilars portfolio spans across immunology and oncology treatments. It also has a portfolio of established brands, including brands in cardiovascular, dermatology and non-opioid pain management. It sells these products through various channels, including drug wholesalers and retailers, hospitals, government agencies and managed health care providers, such as pharmacy benefit managers and other institutions.
Employees
10,000
Date Price Change Volume
17/26/17 $13.52 +0.22% 15,85,825
16/26/16 $13.49 0.00% 26,95,586
15/26/15 $13.49 -0.07% 23,39,617
14/26/14 $13.50 0.00% 20,40,232
13/26/13 $13.50 -0.15% 16,16,592
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
13.52USD
Average target price
11.25USD
Spread / Average Target
-16.79%

Quarterly revenue - Rate of surprise